Novel nitroxoline derivative combating resistant bacterial infections through outer membrane disruption and competitive NDM-1 inhibition
Authors:
Open Access
- 30 January 2024
- journal article
- research article
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 13 (1) , 2294854
Abstract
New Delhi metallo-β-lactamase-1 (NDM-1) has rapidly disseminated worldwide, leading to multidrug resistance and worse clinical prognosis. Designing and developing effective NDM-1 inhibitors is a critical and urgent challenge. In this study, we constructed a library of long-lasting nitroxoline derivatives and identified ASN-1733 as a promising dual-functional antibiotic. ASN-1733 can effectively compete for Ca2+ on the bacterial surface, causing the detachment of lipopolysaccharides (LPS), thereby compromising the outer membrane integrity and permeability and exhibiting broad-spectrum bactericidal activity. Moreover, ASN-1733 demonstrated wider therapeutic applications than nitroxoline in mouse sepsis, thigh and mild abdominal infections. Furthermore, ASN-1733 can effectively inhibit the hydrolytic capability of NDM-1 and exhibits synergistic killing effects in combination with meropenem against NDM-1 positive bacteria. Mechanistic studies using enzymatic experiments and computer simulations revealed that ASN-1733 can bind to key residues on Loop10 of NDM-1, hindering substrate entry into the enzyme's active site and achieving potent inhibitory activity (Ki = 0.22 µM), even in the presence of excessive Zn2+. These findings elucidate the antibacterial mechanism of nitroxoline and its derivatives, expand their potential application in the field of antibacterial agents and provide new insights into the development of novel NDM-1 inhibitors.Keywords
Funding Information
- National Natural Science Foundation of China (32200745)
- Shanghai Sailing Program (21YF1401900)
This publication has 52 references indexed in Scilit:
- The Urinary Antibiotic 5-Nitro-8-Hydroxyquinoline (Nitroxoline) Reduces the Formation and Induces the Dispersal of Pseudomonas aeruginosa Biofilms by Chelation of Iron and ZincAntimicrobial Agents and Chemotherapy, 2012
- The Combination of Colistin and Doripenem Is Synergistic against Klebsiella pneumoniae at Multiple Inocula and Suppresses Colistin Resistance in an In Vitro Pharmacokinetic/Pharmacodynamic ModelAntimicrobial Agents and Chemotherapy, 2012
- In Vitro Synergy of Colistin Combinations against Colistin-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae IsolatesAntimicrobial Agents and Chemotherapy, 2012
- The emerging NDM carbapenemasesTrends in Microbiology, 2011
- Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from IndiaJournal of Antimicrobial Chemotherapy, 2010
- Characterization of a New Metallo-β-Lactamase Gene, bla NDM-1 , and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from IndiaAntimicrobial Agents and Chemotherapy, 2009
- Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studiesClinical Microbiology and Infection, 2008
- Acinetobacter baumannii : Emergence of a Successful PathogenClinical Microbiology Reviews, 2008
- Where will new antibiotics come from?Nature Reviews Microbiology, 2003
- Roles of divalent cations and pH in mechanism of action of nitroxoline against Escherichia coli strainsAntimicrobial Agents and Chemotherapy, 1995